Kohne Pharma concludes worldwide service agreement with Schwarz Biosciences

Haan, 11.01.2010

Kohne Pharma announces the conclusion of a comprehensive service agreement with Schwarz Biosciences GmbH, Monheim, Germany. 

Kohne Pharma undertakes the task to carry out the lifecycle management of approx. 700 marketing authorisations in Europe and further international markets (Mexico, Australia, China, Russia et al.). The stipulated work scope aggregates to approx. 800 renewals, variation procedures and further regulatory tasks per year. Furthermore, Kohne Pharma shall apply for additional marketing authorisations for the concerned products on request of the contractual partner. The service provider Kohne Pharma establishes a second branch office in Monheim and increases its personnel by seven employees for that purpose.

About Kohne Pharma:

Kohne Pharma is a service provider for the German and European pharmaceutical industry. On the one hand the owner-managed company has specialised in the sale and brokerage of marketing authorisations for pharmaceutical products with an emphasis on oncology, ophthalmology and hospital products. On the other hand the company offers comprehensive services in the field of regulatory affairs. The portfolio ranges from application procedures and lifecycle management to pharmacovigilance and quality assurance.

Your contact person:

Klaus Köhl, +49 (0) 2129 53 01 576, This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

• Prasugrel (20/07/2009)
• Biosimilars expansion in the USA (14/07/2009)
• Drug repositioning (14/07/2009)
• Development of International OTC Bradns (08/01/2008)
• Sponsorship to Farmavita.Net (16/12/2007)
• Link Exchange (21/06/2007)
• Pharma Licensing (13/06/2007)
• Snap Shots (07/06/2007)
• Patent Academy (13/04/2007)